Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | PHGDH | O43175 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | TSPO | P30536 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28568423 | 0.98 | ALDH1A1 (0.53) | ALDH1A1KMT2APOLBKDM4EHTT | |
| Hydrochloric Acid SCHEMBL38660739 | 0.98 | ALDH1A1 (0.53) | ALDH1A1KMT2APOLBKDM4EHTT | |
| SCHEMBL9479706 | 0.91 | ALDH1A1 (0.53) | ALDH1A1KMT2APOLBKDM4EHTT | |
| SCHEMBL11658931 | 0.89 | ALDH1A1 (0.51) | ALDH1A1KMT2APOLBKDM4EHTT | |
| SCHEMBL8336238 | 0.89 | ALOX15 (0.53) | ALDH1A1KMT2APOLBKDM4EHTT | |
| SCHEMBL14341655 | 0.87 | SMN1; SMN2 (0.61) | ALDH1A1KMT2APOLBHTTALOX15 | |
| SCHEMBL1177869 | 0.87 | ALDH1A1 (0.53) | ALDH1A1KMT2APOLBKDM4EALOX15 | |
| SCHEMBL320116 | 0.82 | POLB (0.59) | ALDH1A1KMT2APOLBKDM4EHTT | |
| SCHEMBL455438 | 0.82 | KMT2A (0.53) | ALDH1A1KMT2APOLBKDM4EHTT | |
| SCHEMBL17704773 | 0.82 | KMT2A (0.53) | ALDH1A1KMT2APOLBKDM4EHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1504 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119923081-A | Composite material, film and application thereof | 广东聚华印刷显示技术有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-113264844-B | Method for preparing aryl amide compound by catalyzing carbonylation of aryl tertiary amine without metal catalytic system | 宿州学院 | 2023-05-02 | — | — | CN | claimed |
| US-20230084927-A1 | GLUCOSE UPTAKE INHIBITORS AND USES THEREOF | METABOMED LTD. (IL) | 2023-03-16 | — | — | US | claimed |
| EP-4058027-A1 | GLUCOSE UPTAKE INHIBITORS AND USES THEREOF | Metabomed Ltd (IL) | 2022-09-21 | — | — | EP | claimed |
| CN-113603587-B | Preparation method of 2-methyl-4-acetoxyl-2-butenal with stable chromaticity | 万华化学集团股份有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-113603587-A | Preparation method of 2-methyl-4-acetoxyl-2-butenal with stable chromaticity | 万华化学集团股份有限公司 | 2021-11-05 | — | — | CN | claimed |
| CN-113264844-A | Method for preparing aryl amide compound by catalyzing carbonylation of aryl tertiary amine through metal-free catalytic system | 宿州学院 | 2021-08-17 | — | — | CN | claimed |
| US-11084777-B2 | Method for preparing alkylamines | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2021-08-10 | — | — | US | claimed |
| EP-3174932-B1 | CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2021-06-09 | — | — | EP | claimed |
| WO-2021095032-A1 | GLUCOSE UPTAKE INHIBITORS AND USES THEREOF | METABOMED LTD (IL) | 2021-05-20 | — | — | WO | claimed |
| CN-1196718-A | Process for producing azomethine compound and alpha-halogeno-acetanilide | ZENECA LTD (GB) | 1998-10-21 | — | — | CN | claimed |
| US-5756647-A | LIQUID SYSTEM: CATALYST, ACTIVATOR AND SOLVENT | EMS-INVENTA AG (CH) | 1998-05-26 | — | — | US | claimed |
| CN-1178523-A | Aminophenol derivatives | DIICHI PHARMACEUTICAL CO LTD (JP) | 1998-04-08 | — | — | CN | claimed |
| EP-0786483-A2 | Process for an activated anionic lactam polymerisation | EMS-INVENTA AG (CH) | 1997-07-30 | — | — | EP | claimed |
| EP-0255243-B1 | AZOLE DERIVATIVES USEFUL FOR CONTROLLING PLANT DISEASES | SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) | 1991-05-29 | — | — | EP | claimed |
| EP-0255243-A1 | Azole derivatives useful for controlling plant diseases | SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) | 1988-02-03 | — | — | EP | claimed |
| US-4647625-A | Process for modifying conjugated diene polymers | NIPPON ZEON CO., LTD. (JP) | 1987-03-03 | — | — | US | claimed |
| EP-0077963-A1 | 2-Nitro-5-(4-trifluoromethyl-phenoxy)-benzyl derivatives, process for their preparation, and their use as herbicides and plant growth regulators | BAYER AG (DE) | 1983-05-04 | — | — | EP | claimed |
| US-4082822-A | REACTING A THIOL WITH A THIOPHOSPHORYL HALIDE; CATALYST | BAYER AKTIENGESELLSCHAFT (DT) | 1978-04-04 | — | — | US | claimed |
| US-4072712-A | FROM ISOCYANATES, CATALYSIS | BAYER AKTIENGESELLSCHAFT (DT) | 1978-02-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11084777-B2 | Method for preparing alkylamines | ALKBH2, ACR, ALKBH1 | ALDH1A1 880/4885KMT2A 912/4885POLB 1421/4885 |
| US-20230084927-A1 | GLUCOSE UPTAKE INHIBITORS AND USES THEREOF | SLC2A4, SLC2A1, SLC2A2 | ALDH1A1 1014/4885KMT2A 2214/4885POLB 4195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.